« Back BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation

Article in Press

Electrodes in the brain—Ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders

  • Matthis Synofzik

      Affiliations

    • Department for Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany
    • ,
  • Thomas E. Schlaepfer

      Affiliations

    • Department of Psychiatry and Psychotherapy, University Hospital, Bonn, Germany
    • Departments of Psychiatry and Mental Health, The Johns Hopkins University, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence: Thomas E. Schlaepfer, MD, Department of Psychiatry / University Hospital, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.

Received 27 July 2009 ,Revised 12 January 2010 ,Accepted 14 January 2010. Published online 15 February 2010 Uncorrected Proof

References 

  1. Perlmutter JS, Mink JW. Deep brain stimulation. Annu Rev Neurosci. 2006;29:229–257
  2. Abelson JL, Curtis GC, Sagher O, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry. 2005;57(5):510–516
  3. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2394
  4. Nuttin BJ, Gabriels LA, Cosyns PR, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery. 2003;52(6):1263–1272discussion 1272–1274
  5. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121–2134
  6. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461–467
  7. Malone DA, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2009;65:267–275
  8. Schlaepfer TE, Cohen MX, Frick C, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–377
  9. Goodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry. 2009;65(4):263–266
  10. Advanced NeuromodulationSystems (ANS) Inc. BROADEN clinical study. A study of a non-pharmacological device for depression. 2007 [cited 2009 01/06]; Available from: http://www.broadenstudy.com/sb/index.html
  11. Medtronic Inc. Medtronic to pursue major clinical trial of deep brain stimulation as depression treatment. 2006 [cited 2009 01/06]; Available from: http://findarticles.com/p/articles/mi_m0EIN/is_2006_April_25/ai_n26838044?tag=content-inner;col1
  12. Ford PJ. Neurosurgical implants: clinical protocol considerations. Camb Q Healthc Ethics. 2007;16(3):308–311
  13. Fins JJ. A leg to stand on: Sir William Osler and Wilder Penfield's “neuroethics”. Am J Bioeth. 2008;8(1):37–46
  14. Kubu CS, Ford PJ. Ethics in the clinical application of neural implants. Camb Q Healthc Ethics. 2007;16(3):317–321
  15. Glannon W. Stimulating brains, altering minds. J Med Ethics. 2009;35(5):289–292
  16. Farris SM, Gianola FJ. Ethical issues surrounding deep brain stimulation in Parkinson's disease. JAAPA. 2009;22(2):57–58
  17. Kringelbach ML, Aziz TZ. Deep brain stimulation: avoiding the errors of psychosurgery. Jama. 2009;301(16):1705–1707
  18. Farris S, Ford P, DeMarco J, Giroux ML. Deep brain stimulation and the ethics of protection and caring for the patient with Parkinson's dementia. Mov Disord. 2008;23(14):1973–1976
  19. Schiff ND, Giacino JT, Fins JJ. Deep brain stimulation, neuroethics, and the minimally conscious state: moving beyond proof of principle. Arch Neurol. 2009;66(6):697–702
  20. Miller G. Neuropsychiatry: rewiring faulty circuits in the brain. Science. 2009;323(5921):1554–1556
  21. Hildt E. Electrodes in the brain: some anthropological and ethical aspects of deep brain stimulation. Int Rev Information Ethics. 2006;5(9):33–39
  22. Synofzik M, Schlaepfer TE. Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol J. 2008;3(12):1511–1520
  23. Beauchamp T, Childress J. Principles of biomedical ethics. 6th ed. New York: Oxford University Press; 2008;
  24. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–660
  25. Greenberg BD, Malone DA, Friehs GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384–2393
  26. Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet. 2005;366(9495):1420–1422
  27. Mesnage V, Houeto JL, Welter ML, et al. Parkinson's disease: neurosurgery at an earlier stage?. J Neurol Neurosurg Psychiatry. 2002;73(6):778–779
  28. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain. 2002;125(Pt 3):575–583
  29. Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68(4):267–271
  30. Isaias IU, Alterman RL, Tagliati M. Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration. Brain. 2008;131(Pt 7):1895–1902
  31. Synofzik M. [Effective, indicated - and yet without benefit? The goals of dementia drug treatment and the well-being of the patient.]. Z Gerontol Geriatr. 2006;39(4):301–307
  32. Schupbach M, Gargiulo M, Welter ML, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body?. Neurology. 2006;66(12):1811–1816
  33. Agid Y, Schupbach M, Gargiulo M, Mallet L, et al. Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?. J Neural Transm Suppl. 2006;(70):409–414
  34. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896–908
  35. Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006;355(19):1978–1990
  36. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord. 2008;23(3):343–349
  37. Voges J, Hilker R, Botzel K, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord. 2007;22(10):1486–1489
  38. Funkiewiez A, Ardouin C, Krack P, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord. 2003;18(5):524–530
  39. Shapira NA, Okun MS, Wint D, et al. Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry. 2006;77(3):410–412
  40. Piasecki SD, Jefferson JW. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry. 2004;65(6):845–849
  41. Drapier D, Drapier S, Sauleau P, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?. J Neurol. 2006;253(8):1083–1091
  42. Richard IH. Depression and apathy in Parkinson's disease. Curr Neurol Neurosci Rep. 2007;7(4):295–301
  43. Smeding HM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66(12):1830–1836
  44. Haber SN. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat. 2003;26(4):317–330
  45. Carmichael ST, Price JL. Connectional networks within the orbital and medial prefrontal cortex of macaque monkeys. J Comp Neurol. 1996;371(2):179–207
  46. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord. 2007;22(12):1722–1728
  47. Kapoor S. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2009;360(9):931–932author reply 932
  48. Soulas T, Gurruchaga JM, Palfi S, Cesaro P, Nguyen JP, Fenelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008;79(8):952–954
  49. Torres AR, Prince MJ, Bebbington PE, et al. Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry. 2006;163(11):1978–1985
  50. Bewernick BH, Hurlemann R, Matusch A, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in extremely treatment-resistant depression. Biol Psychiatry. 2010;67:110–116
  51. Keller MB, Hirschfeld RM, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol. 2002;17(6):265–271
  52. Nutt DJ, Sharpe M. Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol. 2008;22(1):3–6
  53. Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007;106(4):621–625
  54. Elliott C. Caring about risks. Are severely depressed patients competent to consent to research?. Arch Gen Psychiatry. 1997;54(2):113–116
  55. Bursztajn HJ, Harding HP, Gutheil TG, Brodsky A. Beyond cognition: the role of disordered affective states in impairing competence to consent to treatment. Bull Am Acad Psychiatry Law. 1991;19(4):383–388
  56. Grimes AL, McCullough LB, Kunik ME, Molinari V, Workman RH. Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients. Psychiatr Serv. 2000;51(12):1561–1567
  57. Rudnick A. Depression and competence to refuse psychiatric treatment. J Med Ethics. 2002;28(3):151–155
  58. Herzog J, Reiff J, Krack P, et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson's disease. Mov Disord. 2003;18(11):1382–1384
  59. Mandat TS, Hurwitz T, Honey CR. Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochir (Wien). 2006;148(8):895–897discussion 898
  60. Raucher-Chene D, Charrel CL, de Maindreville AD, Limosin F. Manic episode with psychotic symptoms in a patient with Parkinson's disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci. 2008;273(1-2):116–117
  61. Okun MS, Mann G, Foote KD, et al. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007;78(3):310–314
  62. Okun MS, Bowers D, Springer U, et al. What's in a “smile?” Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2004;10(4):271–279
  63. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267(16):2221–2226
  64. Nuttin B, Gybels J, Cosyns P, et al. Deep brain stimulation for psychiatric disorders. Neurosurgery. 2002;51(2):519
  65. Fins JJ, Rezai AR, Greenberg BD. Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. Neurosurgery. 2006;59(4):713–716
  66. Ford PJ, Kubu CS. Stimulating debate: ethics in a multidisciplinary functional neurosurgery committee. J Med Ethics. 2006;32(2):106–109
  67. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649–659
  68. Kennedy SH, Lam RW. Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics. Bipolar Disord. 2003;5(Suppl 2):36–47
  69. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992;49(10):809–816
  70. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25(5):713–728
  71. Thase ME, Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(Suppl. 13):23–29

 Dr. Schlaepfer received limited support for an Investigator Initiated Study on DBS in resistant major depression from Medtronic Inc., a manufacturer of DBS equipment between 2004 and 2007.

PII: S1935-861X(10)00017-3

doi: 10.1016/j.brs.2010.01.006

« Back BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation

Article in Press

Article Tools

* Image Usage & Resolution